European companies top in access to medicine

European drug companies do better than US counterparts in providing access to medicines for the poor Copyright: malariadrugs_WHO_TDR_Crump

Send to a friend

The details you provide on this page will not be used to send unsolicited email, and will not be sold to a 3rd party. See privacy policy.

European drug companies are doing more than their US counterparts to ensure medicines reach low-income countries, according to a new ranking.

The Access to Medicine Index, produced by the non-profit Access to Medicine Foundation in the Netherlands, ranked 20 major pharmaceutical companies based on eight criteria. These included policies on increasing access, patents, research into neglected diseases, fair pricing systems and donations.

UK-based GlaxoSmithKline came top of the index, with Novo Nordisk of Denmark in second. Merck, in third place, was the only US company in the top seven, with the world’s largest pharmaceutical company, Pfizer, ranking seventeenth behind two Indian generics firms.

Wim Leereveld, head of the Foundation, said Europe’s history and closer proximity to Africa might be one of the reasons behind Europe’s increased activity in the area.

The Access to Medicine Foundation is funded by a variety of organisations including the UK Department for International Development.

Link to full article in Reuters

Link to Access to Medicines Index